NABsys Revenue and Competitors

Providence, RI USA

Location

$105.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NABsys's estimated annual revenue is currently $2.8M per year.(i)
  • NABsys's estimated revenue per employee is $99,643
  • NABsys's total funding is $105.3M.

Employee Data

  • NABsys has 28 Employees.(i)
  • NABsys grew their employee count by 87% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M3626%$208.1MN/A
Add Company

NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care. Our approach builds on existing solid-state technologies to create a whole-genome sequencing technology that employs electronic detection, does not depend on a polymerase, and directly obtains DNA sequence information over hundreds of thousands of bases.

keywords:Biotechnology

$105.3M

Total Funding

28

Number of Employees

$2.8M

Revenue (est)

87%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NABsys News

2022-04-06 - Nabsys Raises $25 Million Equity Round

Funding will fuel further development and commercialization of Nabsys' second-generation High-Definition Mapping platform.

2022-04-06 - Nabsys raises $25M with Hitachi to advance high-resolution ...

A Providence biotech firm has closed on a $25 million equity round in collaboration with a Tokyo electronics giant. Nabsys Inc., a pioneer...

2019-10-03 - Nabsys Raises $21M in Equity Funding

Nabsys, a Providence, RI-based high-definition genome mapping company, closed a $21m equity funding. The round was led by Hitachi High-Technologies Corporation. The company intends to use the funds to finalize product development and support global commercial launch of their HD-Mapping™ whole- ...

2013-03-14 - Boston Roundup: NABsys, Zeo, CommonAngels, Wiggio

Share Share on Facebook Share on Twitter LinkedIn Email Reprints Raising money, shutting down, hiring people and getting acquired—four different entities just about covering all the bases of early stage business and investing news: —NABsys, a Providence, RI-based gene sequencing startup, says ...

2013-03-13 - Nabsys Closes $20M Series D Financing

Nabsys, Inc., a Providence, RI-based life sciences company developing solid-state, single-molecule positional sequencing with broad applicability in DNA analysis, closed a $20m Series D financing. The round was led by new investor Bay City Capital with participation from existing investors Poin ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M284%N/A
#2
$5.3M28-38%N/A
#3
$3.5M28-12%N/A
#4
$2.8M284%N/A
#5
$4.9M288%N/A